PACB
Pacific Biosciences of California
NASDAQ: PACB · HEALTHCARE · MEDICAL DEVICES
$1.59
+8.16% today
Updated 2026-04-30
Market cap
$493.67M
P/E ratio
—
P/S ratio
3.09x
EPS (TTM)
$-1.82
Dividend yield
—
52W range
$1 – $3
Volume
5.8M
Pacific Biosciences of California (PACB) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
+19.3%
Last 4 quarters
Revenue YoY growth
+13.8%
Most recent quarter
EPS YoY growth
+40.0%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-7.6%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-8.1%
2025-11-06
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-12 | $-0.12 | +18.1% | $1.84 | $1.71 | -7.1% |
| 2025-11-06 | $-0.12 | +14.3% | $1.92 | $1.76 | -8.1% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.15 | $-0.12 | +18.1% | $44.65M | +13.8% |
| 2025-09-30 | $-0.14 | $-0.12 | +14.3% | $38.44M | -3.8% |
| 2025-06-30 | $-0.17 | $-0.13 | +23.5% | $39.77M | +10.4% |
| 2025-03-31 | $-0.19 | $-0.15 | +21.1% | $37.15M | -4.3% |
| 2024-12-31 | $-0.17 | $-0.20 | -17.6% | $39.22M | -32.8% |
| 2024-09-30 | $-0.21 | $-0.17 | +19.0% | $39.97M | -28.2% |
| 2024-06-30 | $-0.23 | $-0.64 | -178.3% | $36.01M | -24.3% |
| 2024-03-31 | $-0.28 | $-0.29 | -3.6% | $38.81M | -0.2% |
| 2023-12-31 | $-0.29 | $-0.31 | -6.9% | $58.36M | — |
| 2023-09-30 | $-0.33 | $-0.26 | +21.2% | $55.69M | — |
| 2023-06-30 | $-0.32 | $-0.28 | +12.5% | $47.57M | — |
| 2023-03-31 | $-0.33 | $-0.36 | -9.1% | $38.90M | — |
Frequently asked questions
Has Pacific Biosciences of California beaten earnings estimates?
Pacific Biosciences of California has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of +19.3% over the last 4 quarters.
How does PACB stock react to earnings?
PACB stock has moved an average of -7.6% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.
What is Pacific Biosciences of California's revenue growth rate?
Pacific Biosciences of California reported year-over-year revenue growth of +13.8% in its most recent quarter, with EPS growing +40.0% year-over-year.